Clinical Trial

A Study to Assess Deucravacitinib Safety in Pregnancy

Name: A Study to Assess Deucravacitinib Safety in Pregnancy — clinical trial record (NCT07017699)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess pregnancy and infant outcomes among pregnant participants enrolled in an established North American pregnancy registry (Organization of Teratology Information Specialists \[OTIS\]) who were exposed to deucravacitinib.

Trial Details

NCT Number	NCT07017699
Lead Sponsor	Bristol-Myers Squibb
Conditions	Psoriasis (PsO)
Enrollment	900 participants
Start Date	2025-03-21
Primary Completion	2028-04-01 (estimated)
Study Completion	2029-02-28 (estimated)
Updated on ClinicalTrials.gov	2025-06-12